# Avalo Therapeutics, Inc.: Form 8-K, filed Sep 9, 2024

- Company: [Avalo Therapeutics, Inc.](/companies/avtx.md) (CIK 1534120)
- Form: 8-K
- Filed: 2024-09-09
- Accepted by EDGAR: Sep 9, 2024, 07:22 ET
- Period: 2024-09-09
- Accession: 0001628280-24-039764
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1534120/000162828024039764/avtx-20240909.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1534120/000162828024039764/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1534120/000162828024039764/avtx-20240909.htm

Filed Sep 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-039764. Last ingested by Listed: Oct 29, 2026, 16:18 ET. No prices; not investment advice.